Keiichi Shibahara

$1.18B
as of 10/04/24

About Keiichi Shibahara

Keiichi Shibahara started Amvis Holdings in 2013 to provide home nursing care for patients with permanent illnesses or needing hospice care.

Shibahara worked as a researcher for 20 years, specializing in immunology and molecular biology, before he started Amvis at age 48.

The company was listed on the JASDAQ bourse for startups in 2019 and moved to the Standard exchange in April 2022.

Amvis posted $216 million in revenue in the fiscal year ended in September 2023.

Personal stats

Citizenship

Japan

Source of wealth

Healthcare

Residence

Tokyo, Japan

Birth date

10/09/64 (age 59)

Education

Medical Doctor, Kyoto University

Self-made

self-made

Keiichi Shibahara’s fortune is worth

20K

troy ounces of gold

18K

median U.S. household

12K

median U.S. income

0.024%

U.S. credit card volume

0.005%

GDP of the United States

0.003%

United States debt

Net worth history

Annual ranking

Did you know?

He graduated from Tokai High School and Nagoya University School of Medicine, then did further medical studies at Kyoto University Graduate School of Medicine.

Net worth over time

Real-time ranking

Financial assets

TOKYO | 7071-JP

Amvis Holdings

TOKYO | 7071-JP

Amvis Holdings

TOKYO | 4480-JP

Medley Inc

TOKYO | 9434-JP

Softbank Corp.

Images © Forbes.com. All rights reserved.